Ignite Creation Date:
2024-05-06 @ 9:11 AM
Last Modification Date:
2024-10-26 @ 12:11 PM
Study NCT ID:
NCT02924402
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-04-11
First Post:
2016-09-14
Brief Title:
Study to Evaluate Safety and Tolerability of XmAb13676 Plamotamab in Patients With CD20-expressing Hematologic Malignancies
Sponsor:
Xencor Inc
Organization:
Xencor Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-10
Start Date Type:
ACTUAL
Primary Completion Date:
2024-10
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-01
Completion Date Type:
ESTIMATED
First Submit Date:
2016-09-14
First Submit QC Date:
October 3 2016
Study First Post Date:
2016-10-05
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-04-09
Last Update Post Date:
2024-04-11
Last Update Post Date Type:
ACTUAL